Navigation Links
Interleukin Genetics Reports Fourth Quarter and Year End 2010 Financial Results
Date:3/21/2011

cit$
(6,658,096)$
(5,764,628)Total liabilities and shareholders' deficit$
5,975,000$
3,069,463Statement of Operations Data :Three Months Ended December 31, Twelve Months Ended December 31, 2010200920102009Revenue:Genetic testing service revenue$
479,589$
53,784$  1,940,190$
505,914Contract research revenue-24,912-545,847Other31,1786,39556,98326,669Total revenue510,767185,0911,997,1731,078,430Cost of Revenue364,808291,4971,618,8411,203,647Gross profit (loss)145,959(106,406)378,332(125,217)Operating costs and expenses:Research and development497,452584,1721,925,9753,213,115Research and development reimbursement grant(473,394)-(473,394)-Selling, general and administrative1,173,0971,102,0515,013,9035,575,911Amortization of intangibles28,86328,863115,453115,453Total operating expenses1,226,0181,715,0866,581,9378,904,479Loss from operations(1,080,059)(1,821,492)(6,203,605)(9,029,696)Total other income and (expense), net(87,844)(50,119)(265,215)(148,577)Loss from continuing operationsbefore provision for income taxes(1,167,903)(1,871,611)(6,468,820)(9,178,273)Provision for income taxes----Loss from continuing operations(1,167,903)(1,871,611)(6,468,820)(9,178,273)Income (loss) from discontinued Operations,net of  tax-31,084482,530(1,374,130)Net loss$
(1,167,903)$
(1,840,527)$ (5,986,290)$ (10,552,403)Basic and diluted net income (loss) per common share from:Continuing operations$
(0.03)$
(0.06)($0.18)($0.29)Discontinued operations0.000.000.01(0.04)Net loss$
(0.03)$
(0.06)($0.17)($0.33)Weighted average common shares outstanding,basic and diluted36,583,33032,102,40735,706,27132,007,826
'/>"/>
SOURCE Interleukin Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Interleukin Genetics, Inc. to Present at Biotech Showcase 2011
2. Interleukin Genetics, Inc. Receives Delisting Notification from NYSE Amex
3. Interleukin Genetics to Present at Upcoming Biotech Industry Meetings
4. Interleukin Genetics to Present at the 12th Annual BIO CEO Conference
5. Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market
6. Interleukin Genetics Reports Second Quarter 2009 Financial Results
7. Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
8. Interleukin Genetics to Present at the 2009 BIO Business Forum
9. Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
10. Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
11. Interleukin Genetics Appoints Todd Anthony Walker as Vice President, Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... UCLA wide receiver and Canadian ... and therapy were not working so Zach decided to undergo stem cell therapy ... with precisely guided injections of bone marrow aspirate concentrate (BMAC) harvested with the ...
(Date:9/3/2015)... PUNE, India , September 3, 2015 ... "Chromatography Instruments Market by System (LC (HPLC, UHPLC, Flash), ... (Reverse Phase Columns, Syringe Filters, Vials) - Analysis & ... Instruments Market is expected to reach around 9.223 Billion ... a CAGR of 5.5%. Browse 141 tables ...
(Date:9/2/2015)... , Sept. 2, 2015 ... announced the addition of Jain PharmaBiotech,s new ... to their offering. ... pharmaceutical and biotechnology industries is anticipated. Nanotechnology ... drug development - from formulations for optimal ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
Breaking Biology Technology:UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 2UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3
... HIFU Revenue ... FY2007 Annual Targets Under Review, BEIJING, ... (Nasdaq: CMED ), a leading China-based,medical device company ... and high intensity focused ultrasound tumor,therapy system, today announced ...
... LAKE CITY, Aug. 27 ARUP Laboratories, a ... leader in,innovative laboratory research and development, announced today ... with Premier Purchasing,Partners, L.P., one of the nation,s ... systems. The agreement extends a previous,contract between ARUP ...
... IDM Pharma (Nasdaq:,IDMI) today announced that Jeffrey W. ... Medical Officer and Senior Vice President,of Research and Development. ... report to President and CEO Timothy P. Walbert. ... experience to,IDM Pharma and will lead the regulatory and ...
Cached Biology Technology:China Medical Technologies Reports First Quarter Financial Results 2China Medical Technologies Reports First Quarter Financial Results 3China Medical Technologies Reports First Quarter Financial Results 4China Medical Technologies Reports First Quarter Financial Results 5China Medical Technologies Reports First Quarter Financial Results 6China Medical Technologies Reports First Quarter Financial Results 7China Medical Technologies Reports First Quarter Financial Results 8China Medical Technologies Reports First Quarter Financial Results 9China Medical Technologies Reports First Quarter Financial Results 10China Medical Technologies Reports First Quarter Financial Results 11China Medical Technologies Reports First Quarter Financial Results 12China Medical Technologies Reports First Quarter Financial Results 13China Medical Technologies Reports First Quarter Financial Results 14ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services 2IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 2IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 3IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 4IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 5
(Date:8/25/2015)... and BELLEVUE, Wash. , ... in advanced robotic systems, announced today it will unveil ... ground vehicle (UGV), at the National Tactical Officers Association ... The Guardian S is the first-ever commercially ... of years of research and in-field trials and is ...
(Date:8/20/2015)... OXFORD, CT ., Aug. 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... wallet, announces it has joined The Smart Card Alliance ... the Smart Card Alliance and the Smart Card Alliance ... and visibility to industry peers and thought leaders promoting ...
(Date:8/12/2015)... 12, 2015   MedNet Solutions , an innovative ... of clinical research, is proud to announce that ... SaaS-based eClinical technology platform, has led the way to ... quarters of 2015.   Q2 2015 and Q1 2015 ... by contract value sold in the company,s 15 year ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
... a great health threat, especially since routine smallpox ... treatment currently exists. In the February 1 issue ... and colleagues from Harvard Medical School propose a ... of signaling mediated by the smallpox growth factor ...
... research on prions, the infectious proteins behind "mad cow" disease ... prions in one species to infect other species depends on ... prion. Two studies on the topic appear in the 8 ... suggests that prions from one species rarely infect other species, ...
... tweaked to absorb more contaminants, researchers found that the ... results raised hopes that the plants might become a ... new research findings, published Feb. 1 in the journal ... of the Indian mustard plant, Brassica juncea, absorbed two ...
Cached Biology News:Fibril Shape Is The Basis Of Prion Strains And Cross-species Prion Infection 2Fibril Shape Is The Basis Of Prion Strains And Cross-species Prion Infection 3Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 2Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 3Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 4
... a compact and self-contained multichannel pipettor. ... unique flow-through device, which allows extremely ... system. Optional refill system and ... Will be upgradable to with Tecans ...
... makes it easy to supply microplates, deepwells, ... with operator convenience in mind, iLink incorporates ... of use. The iLink software is the ... or sub-assays, that can be copied and ...
... continue to grow, the need for greater ... become necessary, especially when discerning very similar ... C1si Confocal Microscope System gives you a ... not available in conventional confocal systems, with ...
... Life Science LAS-3000 imaging system combines ... simplified user interface, providing significantly improved ... of modularities. The LAS-3000 provides significantly ... range of applications including: fluorescence, chemifluorescence, ...
Biology Products: